Alpine Woods Capital Investors’s Vertex Pharmaceuticals VRTX Stock Holding History

Alpine Woods Capital Investors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$320K	Sell	716 -686	-49%	-$320K	0.08%	132
2025 Q4	$636K	Sell	1,402 -3,019	-68%	-$1.3M	0.15%	116
2025 Q3	$1.73M	Sell	4,421 -1,173	-21%	-$490K	0.4%	75
2025 Q2	$2.49M	Buy	5,594 +9	+0.2%	+$4.15K	0.59%	58
2025 Q1	$2.71M	Buy	5,585 +3,255	+140%	+$1.52M	0.68%	54
2024 Q4	$938K	Sell	2,330 -2,000	-46%	-$927K	0.18%	112
2024 Q3	$2.17M	Sell	4,330 -1,203	-22%	-$578K	0.38%	80
2024 Q2	$2.59M	Buy	5,533 +140	+3%	+$60.8K	0.4%	80
2024 Q1	$2.12M	Sell	5,393 -2,047	-28%	-$865K	0.42%	83
2023 Q4	$3.03M	Buy	7,440 +996	+15%	+$368K	0.45%	69
2023 Q3	$2.24M	Buy	6,444 +548	+9%	+$192K	0.36%	89
2023 Q2	$2.08M	Buy	5,896 +1,018	+21%	+$343K	0.32%	88
2023 Q1	$1.54M	Sell	4,878 -185	-4%	-$55.5K	0.23%	111
2022 Q4	$1.46M	Buy	5,063 +383	+8%	+$117K	0.21%	107
2022 Q3	$1.35M	Buy	4,680 +493	+12%	+$142K	0.18%	117
2022 Q2	$1.18M	Sell	4,187 -245	-6%	-$65.6K	0.15%	126
2022 Q1	$1.16M	Buy	4,432 +227	+5%	+$53.9K	0.12%	136
2021 Q4	$923K	Buy	4,205 +1,001	+31%	+$195K	0.09%	147
2021 Q3	$581K	Buy	3,204 +310	+11%	+$60.5K	0.06%	175
2021 Q2	$584K	Buy	2,894 +110	+4%	+$23K	0.06%	175
2021 Q1	$598K	Buy	2,784 +3	+0.1%	+$659	0.07%	178
2020 Q4	$657K	Buy	2,781 +1,855	+200%	+$426K	0.08%	170
2020 Q3	$252K	Buy	+926	New	+$255K	0.04%	219

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Alpine Woods Capital Investors's VRTX Position: Q1 2026 in Review

Alpine Woods Capital Investors reduced its Vertex Pharmaceuticals (VRTX) stake by 49% in Q1 2026, selling an estimated $320K and leaving 716 shares worth $320K. The position accounts for 0.08% of the portfolio, ranked #132.

Alpine Woods Capital Investors first reported a position in VRTX in Q3 2020 and has held it in 23 quarters since. The position peaked at $3.03M in Q4 2023. 1,690 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Alpine Woods Capital Investors held 716 shares of Vertex Pharmaceuticals worth $320K as of Q1 2026.
Alpine Woods Capital Investors sold 686 Vertex Pharmaceuticals shares in Q1 2026, an estimated $320K.
Vertex Pharmaceuticals made up 0.08% of Alpine Woods Capital Investors's portfolio in Q1 2026, its #132 holding.
Alpine Woods Capital Investors first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
Alpine Woods Capital Investors's Vertex Pharmaceuticals position peaked at $3.03M in Q4 2023.
1,690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2026, filed 27 May 2026.